Arachidonic Acid and Nonsteroidal Anti-inflammatory Drugs Induce
Conformational Changes in the Human Prostaglandin Endoperoxide
H2 Synthase-2 (Cyclooxygenase-2)*
Timothy
Smith
,
John
McCracken§,
Yeon-Kyun
Shin¶, and
David
DeWitt
From the
Department of Biochemistry and the
§ Department of Chemistry, Michigan State University,
East Lansing, Michigan 48824 and the ¶ Department of
Biochemistry and Biophysics, Iowa State University,
Ames, Iowa 50011
By using the technique of site-directed spin
labeling combined with EPR spectroscopy, we have observed that binding
of arachidonic acid and nonsteroidal anti-inflammatory drugs induces
conformational changes in the human prostaglandin endoperoxide
H2 synthase enzyme (PGHS-2). Line shape broadening
resulting from spin-spin coupling of nitroxide pairs introduced into
the membrane-binding helices of PGHS-2 was used to calculate the
inter-helical distances and changes in these distances that occur in
response to binding various ligands. The inter-residue distances
determined for the PGHS-2 holoenzyme using EPR were 1-7.9 Å shorter
than those of the crystal structure of the PGHS-2 holoenzyme. However,
inter-helical distances calculated and determined by EPR for PGHS-2
complexed with arachidonic acid, flurbiprofen, and SC-58125 were in
close agreement with those obtained from the cognate crystal
structures. These results indicate that the structure of the
solubilized PGHS-2 holoenzyme measured in solution differs from the
crystal structure of PGHS-2 holoenzyme obtained by x-ray analysis.
Furthermore, binding of ligands induces a conformational change in the
holo-PGHS-2, converting it to a structure similar to those obtained by
x-ray analysis. Proteolysis protection assays had previously provided
circumstantial evidence that binding of heme and non-steroidal
anti-inflammatory drugs alters the conformation of PGHS, but the
present experiments are the first to directly measure such changes. The
finding that arachidonate can also induce a conformational change in
PGHS-2 was unexpected, and the magnitude of changes suggests this
structural flexibility may be integral to the cyclooxygenase catalytic mechanism.
*
This work was supported by National Institutes of Health
Grant GM57323.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.